Tracking Results of Ablations to Combat AF Registry Generation 2

Description

The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct concomitant open heart and/or hybrid ablation, and management of the Left Atrial Appendage concomitant to a cardiac ablation.

Conditions

Atrial Fibrillation

Talk to us

Study Overview

On this page

Study Details

Study overview

The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct concomitant open heart and/or hybrid ablation, and management of the Left Atrial Appendage concomitant to a cardiac ablation.

A Multicenter Patient Registry for Outcomes From Comprehensive Ablation Treatments of Atrial Arrhythmias

Tracking Results of Ablations to Combat AF Registry Generation 2

Condition
Atrial Fibrillation
Intervention / Treatment

-

Contacts and Locations

Loma Linda

Loma Linda University Medical Center, Loma Linda, California, United States, 92354

Saint Helena

Adventist Heart Institute (St. Helena Hospital), Saint Helena, California, United States, 94574

Washington

MedStar Washington Hospital, Washington, District of Columbia, United States, 20010

Delray Beach

Delray Medical Center, Delray Beach, Florida, United States, 33484

Gainesville

University of Florida, Gainesville, Florida, United States, 32608

Tampa

St. Joseph's Hospital (BayCare), Tampa, Florida, United States, 33607

Indianapolis

Franciscan Health, Indianapolis, Indiana, United States, 46237

Kansas City

Kansas City Cardiac Arrhythmia Research, Kansas City, Missouri, United States, 66211

Jackson

Jackson Madison County General Hospital, Jackson, Tennessee, United States, 38301

Milwaukee

Medical College of Wisconsin, Milwaukee, Wisconsin, United States, 53226

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Patient has been scheduled by physician(s) to undergo or has undergone cardiac ablation procedure(s) utilizing at least one AtriCure device.
  • 2. Patient is willing to provide written informed consent, (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this Registry), or authorization per institution and geographical requirements.
  • 1. Patient is enrolled in a concurrent trial that may impact the treatment offered by the registry devices.
  • 2. Patient with exclusion criteria required by local governance.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

AtriCure, Inc.,

Study Record Dates

2030-01